(Q35551132)

8 August 2017

1 reference

title

Molecular basis of angiogenesis and cancer (English)

1 reference

8 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206816

18 March 2024

Tiziana Tonini

1 reference

8 August 2017

Francesca Rossi

series ordinal

1 reference

8 August 2017

Pier Paolo Claudio

series ordinal

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

8 August 2017

29 September 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14528279

full work available at URL

18 March 2024

https://www.nature.com/articles/1206816.pdf

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.ONC.1206816

https://www.nature.com/articles/1206816

18 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.ONC.1206816

18 March 2024

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

6549-6556

1 reference

Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Recent advances in cutaneous angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

The pathophysiology of the collateral circulation (arteriogenesis).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Developmental biology. Controlling the cellular brakes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Mechanisms of angiogenesis and arteriogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Regulation of endothelial cell survival and apoptosis during angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF 121 and VEGF 165 but not VEGF 189

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Structure, expression and receptor-binding properties of novel vascular endothelial growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Vascular endothelial growth factor: molecular and biological aspects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

The biology of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Transplacental carcinogenesis by stilbestrol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

1 reference

7 January 2021

Role of angiogenesis in tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Isolation of a tumor factor responsible for angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Down-regulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

B1 integrin activation inhibits in vitro tube formation: effects on cell migration, vacuole coalescence and lumen formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Angiogenesis as a target for tumor treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Openings between defective endothelial cells explain tumor vessel leakiness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Leukocyte-endothelial adhesion and angiogenesis in tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Overexpression of calreticulin modulates protein kinase B/Akt signaling to promote apoptosis during cardiac differentiation of cardiomyoblast H9c2 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Tumor angiogenesis: past, present and the near future

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Molecular angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Differential effect of interleukin-4 and transforming growth factor beta 1 on expression of proto-oncogenes and autocrine insulin-like growth factor II in colorectal carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Angiogenesis: regulators and clinical applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Interleukin-12 inhibits angiogenesis induced by human tumor cell lines in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Endothelial cells of tumor vessels: abnormal but not absent.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Galectin-3 induces endothelial cell morphogenesis and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Oncogenes as inducers of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Angiogenesis inhibitors. New agents in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

The role of thrombospondin-1 in tumor progression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Biological action of leptin as an angiogenic factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Angiogenic activity of adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Angiostatin and angiostatin-related proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Insulin-like growth factor I receptor signaling in transformation by src oncogenes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Calreticulin inhibits vitamin D3signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

VEGF mRNA is Stabilized by Ras and Tyrosine Kinase Oncogenes, as well as by UV Radiation—Evidence for Divergent Stabilization Pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Modulation of cell death in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206816

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206816

18 March 2024

Identifiers

DOI

1 reference

8 August 2017

1 reference